We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. What is new in the classification of peripheral T cell lymphomas?

    In this review focus article, we highlight the main modifications introduced in the latest 2022 International Consensus Classification and World...

    Laurence de Leval, Bettina Bisig in Die Pathologie
    Article Open access 04 December 2023
  2. MicroRNA expression signature as a biomarker in the diagnosis of nodal T-cell lymphomas

    Background

    The diagnosis of T-cell lymphomas is typically established through a multiparameter approach that combines clinical, morphologic,...

    Muhammad Sufyan Bin Masroni, Gracie Wee Ling Eng, ... Soo Yong Tan in Cancer Cell International
    Article Open access 30 January 2024
  3. Central Nervous System Relapse in T and NK cell Lymphomas

    Purpose of Review

    T and NK cell lymphomas are relatively rare and heterogeneous forms of non-Hodgkin lymphoma that are associated with high rates of...

    Eleanor P. Taranto, Stefan K. Barta, Rahul S. Bhansali in Current Hematologic Malignancy Reports
    Article 25 August 2023
  4. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders

    Purpose of Review

    Mature T/NK-cell neoplasms comprise a heterogeneous group of diseases with diverse clinical, histopathologic, immunophenotypic, and...

    Naoki Oishi, Reham Ahmed, Andrew L. Feldman in Current Hematologic Malignancy Reports
    Article 23 October 2023
  5. Mature T-cell and NK-cell lymphomas: updates on molecular genetic features

    Mature T-cell and NK-cell lymphomas are a heterogeneous group of rare and typically aggressive neoplasms. Diagnosis and subclassification have...

    Natasha E. Lewis, Rohan Sardana, Ahmet Dogan in International Journal of Hematology
    Article 13 January 2023
  6. Moving towards biologically informed treatment strategies for T-cell lymphomas

    The rarity and biological heterogeneity of the peripheral T-cell lymphomas has made subtype- and biomarker-driven approaches challenging to realize...

    Robert Stuver, Natasha Lewis, ... Steven M. Horwitz in International Journal of Hematology
    Article 27 December 2022
  7. Extranodal T- and NK-cell lymphomas

    Non-cutaneous extranodal NK/T cell lymphoproliferations constitute a heterogenous group of rare neoplasms, occurring primarily in the...

    Laurence de Leval, Andrew L. Feldman, ... Philippe Gaulard in Virchows Archiv
    Article Open access 07 November 2022
  8. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas

    Nodal T- and NK-cell lymphomas are among the most frequent T-cell malignancies and most subtypes have aggressive clinical behavior. Evolving...

    Andrew L. Feldman, Camille Laurent, ... Philippe Gaulard in Virchows Archiv
    Article 10 October 2022
  9. Radiation Therapy in Peripheral T-Cell and Cutaneous Lymphomas

    Peripheral T-cell lymphomas (PTCLs) represent ≤15% of new non-Hodgkin lymphoma cases. For accurate diagnosis of PTCL, an expert hematopathology...
    Hans Theodor Eich, Khaled Elsayad in Radiation Oncology
    Living reference work entry 2023
  10. T Cell Malignancies

    Malignant transformation of T lymphocytes can result in T cell leukemia or T cell lymphoma. Leukemias originate from immature T cells bone marrow...
    Chapter 2023
  11. Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial

    PI3K-δ inhibitors have shown impressive activity in lymphoid malignancies but have been hampered by autoimmune and infectious toxicities, leading to...

    Steven M. Horwitz, Ajit J. Nirmal, ... Santosha A. Vardhana in Nature Medicine
    Article 17 June 2024
  12. Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas

    Despite recent advances in frontline therapy for diffuse large B-cell lymphoma (DLBCL), at least a third of those diagnosed still will require second...

    Asaad Trabolsi, Artavazd Arumov, Jonathan H. Schatz in Blood Cancer Journal
    Article Open access 08 February 2024
  13. Map** T cell landscapes in B cell lymphomas

    Ralf Küppers in Nature Cell Biology
    Article 20 February 2024
  14. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop

    Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases were discussed at the 2022 European Association for...

    Fina Climent, Alina Nicolae, ... Siok-Bian Ng in Virchows Archiv
    Article Open access 30 August 2023
  15. Low T3 syndrome as a predictor of poor prognosis in peripheral T-cell lymphomas

    Purpose

    The purpose of the study was to evaluate the prognostic value of low T3 syndrome in peripheral T-cell lymphomas (PTCLs).

    Methods ...
    Wenyi Li, Rui Gao, ... Wei Xu in Clinical and Translational Oncology
    Article 18 July 2023
  16. How we treat NK/T-cell lymphomas

    Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a predilection for Asian and South American populations. Epstein–Barr virus...

    Eric Tse, Wei-Li Zhao, ... Yok-Lam Kwong in Journal of Hematology & Oncology
    Article Open access 03 June 2022
  17. First-Line Therapy for Nodal T-cell Non-Hodgkin Lymphomas: an Unmet Need in Hematology

    Purposeof Review

    The main aim of this review is to summarize first-line therapy of nodal T-cell non-Hodgkin lymphoma.

    Recent Findings

    Current...

    Vibor Milunović, Inga Mandac Smoljanović, ... Slavko Gašparov in Current Oncology Reports
    Article 12 April 2023
  18. Management of Peripheral T-cell Lymphomas and the Role of Transplant

    Purpose of Review

    Here, we review the management of peripheral T-cell lymphoma, particularly focusing on the role of autologous and allogeneic stem...

    Nicole C. Foley, Neha Mehta-Shah in Current Oncology Reports
    Article 10 August 2022
  19. 25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas

    The aim of the study was to explore the significance and prognostic value of 25-hydroxy vitamin D (25-(OH) D) deficiency in peripheral T-cell...

    Hao-Rui Shen, **g Tang, ... Wei Xu in Annals of Hematology
    Article 11 November 2023
  20. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop

    Follicular helper T-cell lymphomas (TFH lymphomas) were discussed in session V of the lymphoma workshop of the European Association for...

    Sarah L Ondrejka, Catalina Amador, ... Laurence de Leval in Virchows Archiv
    Article Open access 27 July 2023
Did you find what you were looking for? Share feedback.